Tlr9 Protein — Toll Like Receptor 9 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-protein"> <span class="infobox-title">TLR9 Protein</span> | Property | Value | |----------|-------| | Protein Name | Toll-Like Receptor 9 | | Gene Symbol | TLR9 | | UniProt ID | Q9Y2S7 | | Molecular Weight | ~116 kDa | | Subcellular Location | Endoplasmic reticulum, Endosomes | | Protein Family | Toll-like receptor family | | Associated Diseases | Lupus, Alzheimer's Disease, Parkinson's Disease, Autoimmune Disorders | </div>
Overview
TLR9 (Toll-Like Receptor 9) is an endosomal pattern recognition receptor that recognizes unmethylated CpG DNA motifs common in bacteria and viruses. TLR9 is critical for innate immune responses to DNA pathogens and has important roles in autoimmune diseases and neuroinflammation[@hemmi2022].
Tlr9 Protein — Toll Like Receptor 9 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-protein"> <span class="infobox-title">TLR9 Protein</span> | Property | Value | |----------|-------| | Protein Name | Toll-Like Receptor 9 | | Gene Symbol | TLR9 | | UniProt ID | Q9Y2S7 | | Molecular Weight | ~116 kDa | | Subcellular Location | Endoplasmic reticulum, Endosomes | | Protein Family | Toll-like receptor family | | Associated Diseases | Lupus, Alzheimer's Disease, Parkinson's Disease, Autoimmune Disorders | </div>
Overview
TLR9 (Toll-Like Receptor 9) is an endosomal pattern recognition receptor that recognizes unmethylated CpG DNA motifs common in bacteria and viruses. TLR9 is critical for innate immune responses to DNA pathogens and has important roles in autoimmune diseases and neuroinflammation[@hemmi2022].
| Cell Type | Expression | Function | |-----------|------------|----------| | Plasmacytoid DCs | Very high | Type I IFN production | | B cells | High | Autoantibodies | | Monocytes | Moderate | Cytokine production | | [Microglia](/entities/microglia) | Low-Moderate | CNS immunity |
Therapeutic Targeting
| Strategy | Approach | Status | Notes | |----------|----------|--------|-------| | TLR9 Agonists | Cancer immunotherapy | Approved | Imiquimod analogs | | TLR9 Antagonists | Autoimmune treatment | Research | For lupus | | Antisense | Gene expression | Research | Experimental |
Drug Development
Agonists:
CpG ODN for cancer
Vaccine adjuvants
Anti-viral applications
Antagonists:
IRS954 (IMO-3100)
Suppressive oligodeoxynucleotides
For lupus treatment
Animal Models
Knockout Mice
Tlr9 knockout mice show:
Reduced responses to CpG DNA
Altered autoimmune responses
Changed viral immunity
Behavior changes
Transgenic Models
TLR9 overexpression
Autoimmune models
CNS inflammation models
Research Directions
Current research areas:
TLR9 antagonists: For lupus treatment
Agonists: Cancer immunotherapy
Autoimmunity: Self-DNA recognition
Neuroinflammation: CNS roles
Delivery: Targeted approaches
Background
The study of Tlr9 Protein — Toll Like Receptor 9 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[^4][^5]: Zhou R, et al. TLR9 in Parkinson's disease. Brain Behav Immun. 2020;88:133-143.
See Also
TLR9 Gene — TLR9 gene
TLR3 Protein — Related receptor
[TLR4 Protein — Related receptor](/proteins/tlr4-protein)